BIO Investigación vasca en salud
Centro
Universidad Europea de Madrid
Madrid, EspañaPublications en collaboration avec des chercheurs de Universidad Europea de Madrid (98)
2024
-
A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24
BJU International, Vol. 134, Núm. 4, pp. 568-577
-
Association of Physical Activity and/or Diet with Sleep Quality and Duration in Adolescents: A Scoping Review
Nutrients , Vol. 16, Núm. 19
-
Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities
Pediatric Blood and Cancer, Vol. 71, Núm. 8
-
Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert
Revista Espanola de Cardiologia
-
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain
European Journal of Contraception and Reproductive Health Care, Vol. 29, Núm. 5, pp. 224-232
-
Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis
Immuno-Oncology and Technology, Vol. 21
-
Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial—POSCAL Study
Nutrients, Vol. 16, Núm. 2
-
Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182
-
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study
ESMO Open, Vol. 9, Núm. 10
-
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study
Breast, Vol. 77
-
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
European urology oncology, Vol. 7, Núm. 3, pp. 462-468
-
Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy
Cancers, Vol. 16, Núm. 16
-
Prevalence and prognostic impact of stroke in a national cohort of infective endocarditis
International Journal of Stroke, Vol. 19, Núm. 9, pp. 989-998
-
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
eClinicalMedicine, Vol. 71
-
Relationships between Physical Fitness Attributes, Food Habits and Nutritional Knowledge in Youth Basketball Players
Sport Mont, Vol. 22, Núm. 2, pp. 101-107
-
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain
HIV Medicine
-
The CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3-related muscular dystrophy
Muscle and Nerve, Vol. 69, Núm. 4, pp. 472-476
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422